Health
Johnson & Johnson trials show single-shot COVID-19 vaccine effective; hoping for emergency use OK soon – WSOC Charlotte
A COVID-19 vaccine produced by Johnson & Johnson is provoking an immune response in human trials and is showing it is effective in fighting the virus that has killed…
Studies on the companys one-dose vaccine showed it would produce neutralizing antibodies, or antibodies that fight the virus, soon after the drug was administered.
The vaccine was being tested on people aged 18-55. While common side effects of a vaccination — such as fever, fatigue, headache, and pain at the injection site — were seen in some people, those side effects were not severe.
Dr. Paul Stoffels, chief scientific officer at J&J, said the data gave the company confidence the vaccine will…
-
General22 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General21 hours agoJaguar Land Rover in UK pauses shipments to US
-
General18 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General17 hours agoAustralian share market set to dive as threat of US recession grows